Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,650966,76933,34011,67369,62814,35391,69242,99923,28192,39678,26602,110811
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,203115,22977,9102,13524,15897,12819,26882,17081,10599,19053,12698,42483
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,18068,3230,724,1072,1410,870,2640,1264,338,987,1340,4193
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,380209,49005,17616,42594,32213,21332,54643,41201,16335,21268,19113,64889
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,192899,21480,10534,15819,17641,13564,25346,21959,10469,15120,13305,27662
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,174759,21203,10980,13205,16934,12807,22398,17517,9857,14226,12588,23044
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,361828,33803,15235,44586,36412,18315,47325,38755,14633,15969,18239,78556
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,13460,887,573,1745,692,272,1810,902,894,307,1954,3424
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1030,280,11,199,42,10,116,120,34,18,11,189
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,199800,21735,9987,23846,20523,11673,37943,17683,5648,12385,16965,21412
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,11104,518,282,1197,856,188,2315,1991,250,210,1470,1827
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,17263,667,665,1471,744,1319,458,1196,4926,4611,270,936
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,960,0,136,7,7,0,63,0,322,385,4,36
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,10675,679,424,292,2305,1677,1035,434,986,842,630,1371
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,11635,679,560,299,2312,1677,1098,434,1308,1227,634,1407
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,5740,478,342,171,1118,557,304,337,563,607,364,899
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,40,7,0,16,0,1,1,0,5,2,8,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,144376,23417,6002,29925,5216,4056,22448,23941,3761,2616,7040,15954
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,67312,12980,3300,20999,2013,2962,2917,3986,2311,1457,5300,9087
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6977,1253,366,580,995,128,1181,508,230,155,828,753
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2367,557,325,398,1,32,68,49,185,93,536,123
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,28975,6057,2294,126,596,138,5020,2185,3043,3524,1310,4682
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,21,0,NA,21,NA,0,0,NA,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,32884,5784,1157,7706,321,398,5043,5706,1199,322,1210,4038
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,32905,5784,1157,7727,321,398,5043,5706,1199,322,1210,4038
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,17215,3651,1490,71,206,96,3257,1377,1453,1841,796,2977
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,96478,15786,4611,15737,4168,2961,14827,13967,4318,3895,4743,11465
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,86952,14089,4146,14226,3899,2888,13459,12257,3830,3536,4187,10435
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,183430,29875,8757,29963,8067,5849,28286,26224,8148,7431,8930,21900
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,3624,672,140,781,96,38,602,638,110,66,81,400
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,23922,3701,2440,1895,1406,362,3544,2379,1713,1562,1119,3801
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,174859,28450,8498,28535,7375,5033,27618,26096,7756,6651,8763,20084
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,38563,6665,1698,4508,1449,1001,6411,8170,1205,789,1500,5167
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,135070,19825,5357,24100,7102,4725,20388,21232,6112,4958,6945,14326
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,0,0,0,0,0,0,0,6,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,498,0,6,0,10,207,26,155,NA,93,NA,1
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,48941,11700,2991,6698,4045,202,4856,8273,2961,411,1542,5262
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,49445,11700,2997,6698,4055,409,4882,8428,2967,504,1542,5263
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,6169,1030,193,0,269,82,640,812,1223,1332,290,298
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,37746,8265,3177,4463,722,333,4679,6097,2188,1770,1465,4587
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3673,368,15,639,147,189,243,831,233,105,113,790
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,35321,11742,2358,3202,1013,354,4176,3437,2467,1738,1014,3820
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11673,1479,1063,1903,363,37,1764,2120,215,125,280,2324
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,161587,23602,7077,28903,7275,5335,25035,23862,7045,6568,8681,18204
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,115681,15514,4695,10315,6272,4663,15749,15719,3023,5735,11397,22599
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,4236,283,1007,487,200,1,988,239,45,222,279,485
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4167,753,46,571,148,37,736,394,427,238,187,630
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,590,77,5,145,6,0,57,98,157,0,9,36
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4757,830,51,716,154,37,793,492,584,238,196,666
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,8380,1249,1643,61,238,20,1217,721,540,1022,443,1226
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,23319,3610,1192,4585,1465,835,1642,872,1721,2039,1902,3456
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,120509,14527,7496,16643,7657,9076,11163,7396,4169,6389,6503,29490
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,143828,18137,8688,21228,9122,9911,12805,8268,5890,8428,8405,32946
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,401,0,2,0,0,0,2,0,41,24,8,324
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1058,735,12,100,5,9,27,17,11,1,95,46
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1058,735,12,100,5,9,27,17,11,1,95,46
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,28,26,1,0,0,NA,0,0,1,0,0,0
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3777,1206,15,606,54,14,497,235,399,47,157,547
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3777,1206,15,606,54,14,497,235,399,47,157,547
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1384,33,35,111,7,NA,677,338,15,139,2,27
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,2,2,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1295,164,77,676,19,3,113,83,27,3,64,66
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1297,166,77,676,19,3,113,83,27,3,64,66
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,142,17,10,0,3,NA,48,0,17,28,0,19
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,7,0,NA,7,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3279,370,0,536,27,38,913,652,118,28,76,521
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3286,370,0,543,27,38,913,652,118,28,76,521
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,236,48,10,0,11,NA,23,4,6,49,5,80
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,9,9,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,15855,2434,1031,854,989,1416,1528,926,1368,1517,1580,2212
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5560,710,463,299,428,769,528,532,NA,608,91,1132
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,33758,5246,1873,5075,2626,833,5964,4106,1314,740,1102,4879
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,55182,8399,3367,6228,4043,3018,8020,5564,2682,2865,2773,8223
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,29593,4610,1928,4297,2215,1061,4869,3572,766,717,786,4772
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2501,358,168,122,158,27,391,281,163,367,109,357
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,8865,1127,617,768,636,546,1104,663,612,720,749,1323
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,133996,14186,9890,9980,12651,9376,15308,13183,8611,16023,9434,15354
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,4746913,563082,169063,344587,484929,257663,788522,249520,438543,543769,374167,533068
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,119,63,0,0,0,0,0,0,37,0,8,11
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,11146,758,1003,663,1347,1077,1339,777,1251,907,713,1311
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,15,1,0,0,0,0,0,11,0,0,2,1
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,33,11,0,4,1,0,7,7,0,0,0,3
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,431,46,38,55,23,5,99,55,40,20,19,31
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,206358,27351,10801,32669,12238,9329,30109,27748,9210,11114,10397,25392
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,11527,1628,649,199,473,626,1624,791,1187,1969,281,2100
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,9737,1473,576,166,402,586,1163,517,1025,1753,269,1807
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,9142,1509,525,136,391,507,1152,547,737,1641,240,1757
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,191951,18968,12422,11002,18758,18669,24800,17404,11409,18233,14882,25404
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,185664,17658,12787,9668,18530,17951,24473,15816,11491,18224,14446,24620
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,183251,17321,12531,9456,18518,17296,24099,15441,11459,17985,14454,24691
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,163416,24536,8325,29276,6371,4962,24352,25040,6989,5618,8090,19857
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,198885,20474,13205,10966,18898,18935,25398,17997,10638,19891,15117,27366
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,191312,19077,13274,9587,18582,18225,24702,16180,11032,19602,14728,26323
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,189091,18707,13128,9464,18470,17476,24378,15700,11077,19576,14722,26393
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,153814,21638,8121,29189,6032,4361,23635,24169,6209,5327,7953,17180
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,12135,2061,1031,108,185,973,1653,961,715,1617,321,2510
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,8359,1402,829,121,154,372,1168,550,816,1353,257,1337
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7656,1594,675,147,193,334,937,489,763,1123,261,1140
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,217814,21319,15202,10949,21559,20054,27883,17613,13744,22458,16895,30138
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,13134,1298,848,511,550,1774,2904,940,708,1201,508,1892
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7,0,0,0,7,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,112359,10776,7880,5734,11310,10286,14627,8813,6816,11076,9073,15968
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,97388,9456,6870,4872,9716,9072,12774,7739,5940,9613,7584,13752
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,209747,20232,14750,10606,21026,19358,27401,16552,12756,20689,16657,29720
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,209324,19918,15080,10470,20647,19605,27180,16779,13191,20079,17096,29279
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,208424,19876,15040,10471,20499,19487,26850,16767,13420,19997,17089,28928
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,213038,21156,15002,11224,21396,17681,25778,18609,14358,23061,17391,27382
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,31020,3203,999,1756,3364,3718,4556,2938,1341,1140,2185,5820
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,26247,2732,868,1206,2712,3489,4044,2353,1210,1020,1799,4814
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,57267,5935,1867,2962,6076,7207,8600,5291,2551,2160,3984,10634
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,104856,11418,7858,5743,9184,7810,12715,7915,7094,10407,9378,15334
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,29218,3492,2580,2407,1956,2121,3115,2001,2430,3307,2342,3467
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,19107,3067,1470,1557,1794,1083,2143,1978,1281,1697,1649,1388
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9,0,6,0,0,0,3,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14,4,2,0,0,0,3,1,1,3,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,84385,11167,6669,4919,8305,5966,11427,5422,4748,8465,5586,11711
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,82068,10963,6496,4605,8052,5872,11141,5268,4678,8209,5393,11391
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,44528,2446,4266,1937,4580,4684,5554,2539,2491,5217,4256,6558
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4,0,0,0,0,0,0,0,0,4,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,164826,13814,14790,6878,13920,16717,18042,13310,11657,16970,16246,22482
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,115043,7872,13341,2919,16271,9481,11565,9338,7165,12531,7480,17080
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,48537,2859,6061,1275,6054,5345,5423,3258,2686,6685,2927,5964
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,5,0,0,4,0,0,1,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,3,0,0,3,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,13,0,0,7,0,0,0,0,0,0,0,6
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,498,44,47,64,55,11,61,105,66,25,4,16
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,76721,6341,6950,8557,21754,1227,7340,3959,2241,4550,2740,11062
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,939,146,69,293,181,0,105,58,31,24,19,13
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,13775,1463,1405,3782,780,0,1574,646,1412,318,333,2062
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,34984,17379,693,4664,526,236,3090,1340,414,1847,110,4685
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,33106,17163,321,4601,282,236,2600,989,409,1786,69,4650
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,16243,682,237,0,1281,372,2175,2629,1749,578,676,5864
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,1749,0,0,0,0,0,516,0,0,0,0,1233
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,1036,798,0,69,0,0,0,20,0,0,0,149
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,628,440,0,33,0,0,0,6,0,0,0,149
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,310,45,17,32,23,30,70,41,7,5,8,32
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3179,47,36,0,0,64,2175,33,298,404,54,68
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,269,32,30,8,24,31,48,40,NA,8,16,32
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,48,5,2,0,3,6,16,3,0,2,6,5
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1395,115,272,210,40,31,168,90,68,88,211,102
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,33834,2351,4209,10068,794,1034,4015,1733,851,2055,2119,4605
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,457,72,35,42,20,3,73,55,47,42,28,40
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1350,251,117,256,17,0,392,41,33,110,31,102
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,202089,38950,14307,50972,6845,2029,31109,18440,5929,11289,7219,15000
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,429938,132669,22167,55401,4918,3500,67354,44152,14969,29452,12818,42538
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,156732,20812,9439,50505,5149,1824,25561,13759,4652,7055,6086,11890
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,547450,111560,33532,77449,12868,8771,90432,71944,19609,33569,22400,65316
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,358821,59762,23746,101477,11994,3853,56670,32199,10581,18344,13305,26890
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,977388,244229,55699,132850,17786,12271,157786,116096,34578,63021,35218,107854
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,18241,5983,1440,3890,342,12,2830,875,395,483,157,1834
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,10778,3107,868,2283,134,23,1827,628,246,289,84,1289
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,29019,9090,2308,6173,476,35,4657,1503,641,772,241,3123
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,3442932,561762,235767,938667,96596,28871,462883,256887,147682,291003,97333,325481
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,43222639,6025077,2508054,6596415,2591381,1905445,5831029,4516788,1950485,2749498,2888989,5659478
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,229693,52980,15477,40519,2582,1769,31027,15469,14653,21657,4372,29188
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4855,960,402,599,170,36,983,318,380,349,253,405
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,447322,32184,32760,65676,24474,8327,86371,20385,3493,15165,6393,152094
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,0,0,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,1356526,200261,160647,149096,125095,2983,125559,180941,31477,141159,70686,168622
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,380238,96982,8819,94672,20579,1204,45765,13559,6991,20092,20683,50892
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,51372,11402,3539,3026,5742,2616,10557,2137,313,2067,5379,4594
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,1273687,1250662,NA,NA,NA,NA,NA,23025,NA,NA,NA,NA
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9507012,1516394,302605,5617278,133812,66311,502590,347859,292864,133415,167038,426846
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,98879,17805,5435,11180,3939,2309,12983,13709,3030,1544,3714,23231
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,206142,38273,20551,42367,6623,4803,28145,13686,21766,5504,6313,18111
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2091,257,105,659,67,84,391,146,117,31,51,183
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,131735,17574,10585,22172,6174,5448,20804,11154,12126,5188,5290,15220
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,805,64,58,283,17,13,153,44,37,12,20,104
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,191262,28200,12257,20735,16729,14620,29214,20446,9165,6770,15756,17370
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,760,30,15,77,13,149,93,307,20,3,10,43
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,529139,84047,43393,85274,29526,24871,78163,45286,43057,17462,27359,50701
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3656,351,178,1019,97,246,637,497,174,46,81,330
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,251776,24823,17105,26651,18711,6556,39625,26925,12950,12103,19557,46770
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,43291,3519,10444,12902,1639,598,1768,1751,4985,1402,921,3362
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,46818,3650,2357,14277,3003,2236,4211,1297,2066,1386,1522,10813
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,182459,20300,10292,21864,12562,11079,35602,15831,8565,7939,18208,20217
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,272568,27469,23093,49043,17204,13913,41581,18879,15616,10727,20651,34392
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,570743,27909,16080,33548,9473,4962,52341,48527,291581,15228,25796,45298
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3447,143,289,345,72,45,518,477,627,343,203,385
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,699,9,20,27,0,5,371,3,16,241,4,3
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,290400,25960,18490,26560,27250,17460,25560,9110,36490,23930,30470,49120
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,350690,39000,23500,20000,27020,25500,48130,25600,27940,32000,33500,48500
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,22180,2560,1220,0,0,0,18400,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,334127,36460,26290,20150,21630,25757,45890,26110,27560,30920,31140,42220
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,284783,25940,14480,26410,32640,17203,9400,8600,36870,25010,32830,55400
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,366730,30620,10380,38550,23070,28150,36830,21290,46510,51110,38070,42150
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,517100,56700,31320,30240,38640,50720,88080,45770,28990,45840,34080,66720
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12870,490,0,0,0,0,12380,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,487540,51410,33410,30010,34460,35740,79490,47640,31750,44650,36250,62730
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,383420,35420,8290,38780,27250,43130,33040,19420,43750,52300,35900,46140
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,500910,74100,23600,44900,28730,26890,34240,17900,69600,57530,51160,72260
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,891220,111100,59040,87780,51000,62000,108080,72000,64200,74000,52000,150020
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11020,1760,0,0,0,0,9260,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,875620,130860,59040,92060,43750,43710,91120,75160,57960,64460,62040,155460
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,505490,52580,23600,40620,35980,45180,41940,14740,75840,67070,41120,66820
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,383075,70110,11520,42830,25850,16870,45980,17011,48400,40034,52210,12260
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,463410,64500,21560,28000,27500,29490,79500,26000,26170,50500,46000,64190
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,12870,0,0,0,0,0,12870,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,432670,55420,22680,28540,24640,23120,72380,27180,21230,48440,44640,64400
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,400945,79190,10400,42290,28710,23240,40230,15831,53340,42094,53570,12050
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,5110,0,0,NA,5110,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,6800,0,0,NA,6800,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,6650,0,0,NA,6650,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,5260,0,0,0,5260,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,283610,13510,13950,36830,22500,13660,39260,14240,57620,38030,13080,20930
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,327610,33500,15000,52000,19000,21500,58500,29850,19260,25000,12000,42000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,16790,1620,0,0,0,0,15170,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,311960,32350,16450,48440,18350,17280,55390,30430,16000,25930,12300,39040
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,282470,13040,12500,40390,23150,17880,27200,13660,60880,37100,12780,23890
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,279120,19005,13395,33430,17135,16915,23000,11785,42015,32035,33290,37115
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,309550,30500,21190,16800,24500,29750,52000,23970,18840,31000,20000,41000
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,12500,1600,0,0,0,0,10900,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,288020,27740,21580,15220,22685,22090,49690,25415,19180,30530,19110,34780
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,288150,20165,13005,35010,18950,24575,14410,10340,41675,32505,34180,43335
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,143020,8140,13780,24640,8500,5680,27110,15020,8460,8010,10630,13050
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,142020,21210,3490,30000,5070,3500,25840,22730,3680,4500,5500,16500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,7460,280,0,0,0,0,7180,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,136270,19580,6050,27780,4230,2700,21750,22310,4540,5230,5830,16270
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,141310,9490,11220,26860,9340,6480,24020,15440,7600,7280,10300,13280
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,53554,5479,2267,2614,9621,5084,5394,5125,3669,5320,6455,2526
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,24683,1800,1433,1400,3600,1150,4200,2600,1800,1800,1600,3300
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1114,219,0,0,0,0,895,NA,0,0,0,0
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,33601,1771,1461,1276,2416,2923,3322,11645,1372,1985,1705,3725
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,43522,5289,2239,2738,10805,3311,5377,-3920,4097,5135,6350,2101
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,3430670,85240,40640,367700,186430,115320,2289000,32800,221400,70200,21940,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,1897410,117360,65500,129600,155830,64800,689400,81420,292000,301500,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,983640,8640,0,0,0,0,975000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1828030,112660,47100,50940,142170,100270,771000,83220,232600,269100,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2516410,81300,59040,446360,200090,79850,1232400,31000,280800,102600,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,172224,10072,7335,14760,29050,10670,13487,10000,19950,20900,20135,15865
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,86321,9500,4471,7500,12400,5000,8000,9950,8000,9000,4500,8000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,7013,3231,0,0,0,0,3782,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,81553,9274,4594,6280,9610,4420,9815,8970,8100,10230,4625,5635
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,169979,7067,7212,15980,31840,11250,7890,10980,19850,19670,20010,18230
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,64783,1976,7375,2861,12650,2620,15362,6300,3270,2365,6850,3154
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,12930,600,3225,600,1800,1100,0,2000,1320,885,700,700
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,7171,61,0,0,0,0,7110,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,12242,841,1915,202,940,849,2402,2500,730,845,415,603
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,58300,1674,8685,3259,13510,2871,5850,5800,3860,2405,7135,3251
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3134,NA,0,200,0,0,1164,120,450,0,1000,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,5500,NA,0,1400,0,0,2000,300,300,0,700,800
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,0,0,0,664,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,3100,NA,0,1000,0,0,500,300,300,0,500,500
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4870,0,0,600,0,0,2000,120,450,0,1200,500
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,2,NA,0,NA,0,2,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,-2,0,0,0,0,-2,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1347750,143150,0,407900,233000,37000,415200,52100,0,0,59400,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,1495000,150000,0,270000,330000,180000,10000,105000,210000,240000,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,30000,NA,0,0,0,0,30000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,1185150,187700,0,163900,261800,80500,120600,105000,165000,72750,27900,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,1627600,105450,0,514000,301200,136500,274600,52100,45000,167250,31500,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,63000,NA,0,NA,0,63000,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,39500,NA,0,NA,0,39500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,46500,NA,0,NA,0,46500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,56000,0,0,0,0,56000,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,14064,NA,837,469,720,1168,6872,658,1199,537,1545,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,7938,NA,800,550,800,503,2160,955,700,920,550,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,148,NA,0,0,0,0,148,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,7746,NA,1160,474,723,1230,953,854,603,826,864,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,14108,0,477,545,797,441,7931,759,1296,631,1231,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,113420,NA,0,16300,16200,56200,4000,14700,0,0,6020,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,189000,NA,0,11600,43800,15200,41600,200,38600,38000,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,153410,NA,0,12350,39800,11400,41400,5700,34000,5200,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,149010,0,0,15550,20200,60000,4200,9200,4600,32800,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,305491,20320,19271,45355,16350,15466,42600,12050,59940,35700,21799,16640
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,227547,22000,15945,49000,18000,4462,42000,21250,11090,16000,6000,21800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,19000,800,0,0,0,0,18200,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,201621,20240,13651,35610,17250,6550,31600,21250,6600,16400,8240,24230
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,312417,21280,21565,58745,17100,13378,34800,12050,64430,35300,19559,14210
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2772350,261300,26330,127400,597210,86000,167600,59850,606100,392400,192900,255260
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,1763950,167800,113500,74800,216000,93600,292400,113150,140500,158000,153400,240800
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,205000,101700,0,0,0,0,103300,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1717000,180050,108690,74600,170000,96500,270600,115300,123800,188800,152800,235860
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2614300,147350,31140,127600,643210,83100,86100,57700,622800,361600,193500,260200
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,362233,51120,20700,9360,16300,12475,39500,16700,76110,73900,22388,23680
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,136125,13000,16500,3000,10200,2995,26500,16400,10530,8000,10500,18500
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,31700,12600,0,0,0,0,19100,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,125733,9780,11420,2860,10950,3600,21400,13900,6500,15800,12998,16525
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,340925,41740,25780,9500,15550,11870,25500,19200,80140,66100,19890,25655
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,117,19,1,12,5,9,64,1,1,2,1,2
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,411,58,168,129,4,1,28,2,4,NA,3,14
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,98,8,27,38,5,NA,19,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,509,66,195,167,9,1,47,2,4,NA,3,15
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,267,38,63,117,9,NA,30,2,5,NA,2,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,15,2,2,6,1,NA,2,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,282,40,65,123,10,NA,32,2,5,NA,3,2
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,404,50,4,115,5,4,45,NA,3,1,2,175
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,21,6,NA,4,NA,NA,10,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,425,56,4,119,5,4,55,1,3,1,2,175
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,518,42,98,139,8,8,121,4,2,6,9,81
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,44,4,14,8,2,3,13,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,562,46,112,147,10,11,134,4,2,6,9,81
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,150,11,32,80,6,NA,14,1,2,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,73,2,15,47,1,NA,5,2,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,223,13,47,127,7,NA,19,3,2,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,39,1,NA,26,1,1,7,1,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,13,NA,NA,11,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,52,1,NA,37,1,1,8,1,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,49,1,NA,39,NA,2,2,NA,NA,NA,2,3
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,47,NA,NA,41,1,NA,2,NA,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,96,1,NA,80,1,2,4,NA,1,NA,2,5
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,385,19,74,186,10,6,56,10,9,NA,3,12
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,177,10,32,80,6,2,19,4,2,NA,2,20
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,562,29,106,266,16,8,75,14,11,NA,5,32
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,9,NA,NA,6,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,113,26,4,56,1,NA,17,1,NA,NA,2,6
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,68,11,1,21,NA,NA,26,1,NA,NA,NA,8
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,190,37,5,83,1,NA,45,2,NA,NA,2,15
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,21,NA,NA,13,NA,NA,6,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,319,17,12,117,3,NA,102,11,1,1,NA,55
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,230,18,7,108,4,NA,50,6,NA,2,8,27
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,570,35,19,238,7,NA,158,17,1,3,8,84
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,63,2,5,45,2,NA,3,2,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,575,68,39,161,16,NA,139,18,6,16,9,103
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,920,130,108,139,33,NA,245,30,5,18,32,180
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1558,200,152,345,51,NA,387,50,11,34,41,287
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,2,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,12,NA,1,3,NA,NA,6,NA,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,15,NA,1,5,NA,NA,7,NA,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,80,2,NA,58,1,NA,13,1,1,1,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,307,41,8,54,12,NA,134,2,NA,1,2,53
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,191,50,6,16,7,NA,82,1,NA,4,1,24
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,578,93,14,128,20,NA,229,4,1,6,3,80
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,52,3,1,7,NA,NA,21,1,NA,NA,NA,19
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,5,NA,NA,2,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,57,3,1,9,NA,NA,24,1,NA,NA,NA,19
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,25,1,2,7,1,NA,9,1,1,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,768,81,52,214,41,NA,163,29,12,6,35,135
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1489,195,117,393,43,NA,265,38,61,22,67,288
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2282,277,171,614,85,NA,437,68,74,28,103,425
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,23,1,NA,14,1,NA,6,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,282,35,14,34,8,NA,118,25,NA,NA,3,45
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,265,32,47,16,2,NA,118,9,1,NA,11,29
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,570,68,61,64,11,NA,242,34,1,NA,14,75
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,4,NA,NA,1,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,4,NA,NA,1,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,38,6,NA,23,NA,NA,5,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,38,6,NA,23,NA,NA,5,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,26,6,NA,8,NA,NA,8,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,26,6,NA,8,NA,NA,8,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,21,2,1,15,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,21,2,1,15,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,213,24,2,60,4,1,19,67,2,NA,2,32
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,213,24,2,60,4,1,19,67,2,NA,2,32
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,22,NA,3,15,1,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,675,21,55,324,79,NA,95,3,1,NA,7,90
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,150,9,22,44,11,NA,30,1,1,NA,4,28
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,847,30,80,383,91,NA,127,4,2,NA,11,119
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,50,NA,1,2,14,NA,19,1,NA,NA,11,2
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,9,1,2,2,1,NA,2,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,61,3,3,4,15,NA,21,1,NA,NA,12,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,12,NA,1,1,3,NA,4,NA,NA,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,15,1,1,1,4,NA,4,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,162,13,76,66,NA,NA,5,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1479,155,4,1071,11,NA,124,6,2,NA,4,102
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1045,211,3,663,5,NA,77,10,13,NA,3,60
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2686,379,83,1800,16,NA,206,16,15,NA,7,164
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,54,5,8,32,NA,NA,7,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1190,144,37,482,10,NA,274,30,NA,2,11,200
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1187,209,55,351,11,NA,311,51,2,1,25,171
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2431,358,100,865,21,NA,592,81,2,3,36,373
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,21,NA,13,1,1,NA,1,3,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,906,26,318,104,69,NA,197,95,2,9,13,73
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,648,9,196,45,11,NA,186,109,17,14,47,14
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1575,35,527,150,81,NA,384,207,19,23,60,89
